lobster-drug-discovery
PulseGate's liveness check found it on 13 Sep 2026; it is registered on PyPI and has been in the index since 27 Jun 2026. How this is checked
lobster-drug-discovery is an open-source AI agent for automating drug discovery tasks such as target identification, compound profiling, and clinical translation. It is designed for researchers and scientists in bioinformatics and pharmacogenomics, leveraging AI to streamline discovery workflows.
Inferred · not functionally tested
Overview
4 featuresPurpose: Accelerates drug discovery by automating target identification and compound profiling using AI agents.
Inferred · not functionally tested
Audience: bioinformatics researchers and drug discovery scientists
Inferred · not functionally tested
Functions: agents, workflow_automation, data_extraction
Inferred · not functionally tested
Interfaces: API: unknown · MCP: unknown · CLI: indicated (inferred, not tested) · Self-hosting: unknown
Recorded constraints: pricing: open_source · license: AGPL-3.0-or-later · platforms: CLI · deployment: cli
Constraint provenance is unknown; confirm requirements with the publisher.
Record sources: pypi.org. These links do not verify the individual claims.
lobster-drug-discovery sits in PulseGate's Frameworks & runtimes category. Inferred · not functionally tested: It accelerates drug discovery by automating target identification and compound profiling using AI agents. Inferred · not functionally tested: It is built as an open-source project for bioinformatics researchers and drug discovery scientists. Basis unknown · not verified: The project is open source (AGPL-3.0-or-later). Basis unknown · not verified: It ships for the command line.
the-omics-os builds and maintains lobster-drug-discovery, and it first shipped in 2026. The project is developed in the open on GitHub with 34 stars and 53 commits in the last 90 days. Inferred · not functionally tested: Key capabilities include target identification, compound profiling, and clinical translation.
Summary written by a language model from the project’s public pages.
Tasks: Inferred · not functionally tested
- Target identification
- Compound profiling
- Clinical translation
- Pharmacogenomics
Topics: Inferred · not functionally tested
Built with & integrations
Trust & compliance
Indexing history
1What PulseGate has recorded for this listing
- Indexed7 Oct · 00:07 UTClobster-drug-discovery seen via PyPI Fresh FeedSource: PyPI Fresh Feed · Open
Frequently asked questions about lobster-drug-discovery
- What is lobster-drug-discovery?
- Inferred · not functionally tested: Lobster-drug-discovery accelerates drug discovery by automating target identification and compound profiling using AI agents. It is catalogued under Frameworks & runtimes on PulseGate.
- Who should use lobster-drug-discovery?
- Inferred · not functionally tested: lobster-drug-discovery is an open-source project built for bioinformatics researchers and drug discovery scientists.
- Does lobster-drug-discovery have a free plan?
- Basis unknown · not verified: Yes — lobster-drug-discovery is open source under the AGPL-3.0-or-later license and free to use.
- What platforms does lobster-drug-discovery run on?
- Basis unknown · not verified: lobster-drug-discovery runs on the command line.
- Is lobster-drug-discovery still active?
- PulseGate's liveness check found it on 13 Sep 2026. Its GitHub repository shows 53 commits in the last 90 days.
- What are alternatives to lobster-drug-discovery?
- Similar projects tracked by PulseGate include lobster-proteomics, lobster-genomics, and lobster-ai.lobster-proteomicslobster-genomicslobster-ai
- Who develops lobster-drug-discovery?
- lobster-drug-discovery is developed by the-omics-os.
- When did lobster-drug-discovery launch?
- lobster-drug-discovery first shipped in 2026.
Similar projects
Closest matches by what these projects do